Renin-angiotensin system and cardiovascular risk.
Strauss
Martin H
MH
Division of Cardiovascular Surgery, Saint Michael's Hospital and Division of Cardiology, North York General Hospital, Toronto, Ontario M2K 1E1, Canada. Dr.Marty@bellnet.ca
Hall
Alistair
A
D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000139:chemically induced / Q000517:prevention & control*; D011945:Receptors, Angiotensin; D012084:Renin-Angiotensin System / Q000187:drug effects*; D012306:Risk
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin